OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Curcumin supplementation effect on liver enzymes in patients with nonalcoholic fatty liver disease: a GRADE-assessed systematic review and dose–response meta-analysis of randomized controlled trials
Mahdi Vajdi, Shirin Hassanizadeh, Reza Hassanizadeh, et al.
Nutrition Reviews (2024)
Closed Access | Times Cited: 7
Mahdi Vajdi, Shirin Hassanizadeh, Reza Hassanizadeh, et al.
Nutrition Reviews (2024)
Closed Access | Times Cited: 7
Showing 7 citing articles:
Dietary Phytochemicals in Health and Disease: Mechanisms, Clinical Evidence, and Applications—A Comprehensive Review
Md. Sakhawot Hossain, Md Abdul Wazed, S T Asha, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 3
Open Access
Md. Sakhawot Hossain, Md Abdul Wazed, S T Asha, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 3
Open Access
Effect of polyphenols against complications of COVID-19: current evidence and potential efficacy
Mahdi Vajdi, Arash Karimi, Shirin Hassanizadeh, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 2, pp. 307-327
Closed Access | Times Cited: 4
Mahdi Vajdi, Arash Karimi, Shirin Hassanizadeh, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 2, pp. 307-327
Closed Access | Times Cited: 4
Curcumin Supplementation as a Preventive Strategy Against Tamoxifen-Induced Nonalcoholic Fatty Liver Disease in ER+ Breast Cancer Patients: A Triple-Blind Randomized Placebo-Controlled Trial
Simin Hemati, Fatemeh Mehrabinejad, Mohammadreza Elhaie, et al.
Journal of Dietary Supplements (2025), pp. 1-10
Closed Access
Simin Hemati, Fatemeh Mehrabinejad, Mohammadreza Elhaie, et al.
Journal of Dietary Supplements (2025), pp. 1-10
Closed Access
Effects of Portulaca oleracea (purslane) on liver function tests, metabolic profile, oxidative stress and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: a randomized, double-blind clinical trial
Narges Milkarizi, Hanieh Barghchi, Saba Belyani, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 2
Narges Milkarizi, Hanieh Barghchi, Saba Belyani, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 2
Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions
X. Li, Meng Li
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1073-1073
Open Access | Times Cited: 2
X. Li, Meng Li
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1073-1073
Open Access | Times Cited: 2
Is curcumin the new kid on the block for the treatment of MASH?
Shira Zelber‐Sagi, Jörn M. Schattenberg
Hepatology (2024)
Closed Access | Times Cited: 1
Shira Zelber‐Sagi, Jörn M. Schattenberg
Hepatology (2024)
Closed Access | Times Cited: 1
Does curcumin improve liver enzymes levels in nonalcoholic fatty liver disease ? A systematic review, meta‐analysis, and meta‐regression
Jerónimo Aragón‐Vela, Antonio Jesús Sánchez-Oliver, Jesús R. Huertas, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 8, pp. 4261-4271
Closed Access | Times Cited: 1
Jerónimo Aragón‐Vela, Antonio Jesús Sánchez-Oliver, Jesús R. Huertas, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 8, pp. 4261-4271
Closed Access | Times Cited: 1
